899,000 Mpox Vaccines Available in the African region

The World Health Organization (WHO) today announced the Access and Allocation Mechanism (AAM) for mpox has allocated an initial 899,000 vaccine doses for nine countries across the African region that are hit hard by the current Clade Ib mpox surge.

By the end of 2024, over 5.85 million vaccine doses are expected to be available to the Mpox Vaccines AAM.

As of November 6, 2024, the most significant number of JYNNEOS vaccine doses, 85% of the allocation, will go to the Democratic Republic of the Congo (DRC) as the most affected country, reporting 80% of laboratory-confirmed mpox cases in Africa in 2024.

Limited vaccination with Bavarian Nordic A/S MVA-BN® (JYNNEOS®) has recently begun in the DRC and Rwanda.